CIK 0001729427 · Non-accelerated filer<br>Smaller reporting company
CNS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CNSP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 822318545
- Phone
- 1-800-946-9185
- Business address
- 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-14 | Levin Rami CEO and President | Option exercise | −4,750 | 4,750 | ||
| 2026-08-14 | Levin Rami CEO and President | Option exercise · Restricted Stock Units | −4,750 | 14,250 | ||
| 2026-05-18 | Fisher Michal Director | Purchase | +2,000 | $5.00 | $10K | 2,000 |
| 2026-05-18 | Charles Faith L. Director | Purchase | +7,100 | $4.79 | $34K | 7,100 |
| 2026-03-02 | Faulkner Eric Chief Technology Officer | Grant or award · Restricted Stock Units | +9,500 | 9,500 | ||
| 2026-03-02 | O'Loughlin Steve Chief Financial Officer | Grant or award · Restricted Stock Units | +9,500 | 9,500 | ||
| 2026-01-01 | Levin Rami CEO and President | Grant or award · Restricted Stock Units | +19,000 | 19,000 | ||
| 2025-11-17 | Keyes Jeffry R. Director | Grant or award · Option to purchase common stock | +1,517 | 1,517 | ||
| 2025-11-17 | Cockroft Bettina M. Director | Grant or award · Option to purchase common stock | +1,517 | 1,517 | ||
| 2025-11-17 | Mahery Amy Director | Grant or award · Option to purchase common stock | +1,517 | 1,517 | ||
| 2025-11-17 | Climaco John M Chief Executive Officer | Grant or award · Option to purchase common stock | +9,761 | 9,761 | ||
| 2025-11-17 | Charles Faith L. Director | Grant or award · Option to purchase common stock | +1,517 | 1,517 | ||
| 2025-11-17 | Downs Christopher Chief Financial Officer | Grant or award · Option to purchase common stock | +4,881 | 4,881 | ||
| 2025-11-17 | Gumulka Jerzy Director | Grant or award · Option to purchase common stock | +1,517 | 1,517 | ||
| 2024-04-08 | Mahery Amy Director | Grant or award · Option to purchase common stock | +17,500 | 29,920 | ||
| 2024-04-08 | Mahery Amy Director | Grant or award · Restricted Stock Units | +17,500 | 47,420 | ||
| 2024-04-08 | Keyes Jeffry R. Director | Grant or award · Option to purchase common stock | +17,500 | 62,928 | ||
| 2024-04-08 | Keyes Jeffry R. Director | Grant or award · Restricted Stock Units | +17,500 | 80,428 | ||
| 2024-04-08 | Gumulka Jerzy Director | Grant or award · Option to purchase common stock | +17,500 | 129,594 | ||
| 2024-04-08 | Gumulka Jerzy Director | Grant or award · Restricted Stock Units | +17,500 | 147,594 |
Page 1 of 6 · 110 trades